The European Patent Office confirms the validity of Arkema's Patent for the manufacture of Difluoromethane
The EPO decision maintains Arkema's European patent as initially granted, rejecting the action brought in Europe to challenge its validity. This Arkema European patent is the counterpart of American patent US 5900514, currently under litigation in the United States against the company Great Lakes.
By confirming Arkema as the rightful owner of this difluoromethane manufacturing process, the EPO decision reinforces the value of Arkema's patent portfolio in this field. Recently, the EPO Board of Appeal had already ruled in favour of Arkema in respect of another European Patent (EP 751108) also for the manufacture of difluoromethane.
Most read news
Other news from the department politics & laws
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.